As more people who came in contact with the Patrick Sawyer, the first
Ebola fatality in Nigeria begin to show symptoms associated with the
virus, the Nigerian government said it has reached out to United States
health authorities for access to the experimental drug used to treat two
American volunteer doctors who were infected with the disease while
treating Ebola patients in Liberia.
The Minister of Health,
Onyebuchi Chukwu, told Journalists that Nigeria government is in
consultation with the U.S. Centre for Disease Control, CDC, to acquire
the “secret serum” used in the treatment of American doctors, Kent
Brantly and Nancy Writebol. The experimental “secret Serum” is said to
have had an almost immediate effect on the doctors and their health
improved considerably.
Though it reportedly proved effective in
the treatment of primates, the Americans were the first humans to be
treated with the drug known as “ZMapp,” and developed by a San
Diego-based biotech firm, Mapp Biopharmaceutical Inc.
“We are in
touch with the Americans. Yesterday, I spoke on telephone with the
Director of the US Centre for Disease Control and Prevention, Dr Tom
Freiden. We spoke at length, and we have exchanged emails. Yesterday, I
inaugurated the Treatment Research Group and one of its terms of
reference is to collaborate with similar working groups across the
world. Now that they have started work, they will get in touch with the
Americans and understand what they are doing and whether we have access
to similar opportunity,” said Mr Chukwu.
The minister added that
he has confidence in the committee of medical and health experts
constituted by the government to develop a drug for the treatment of the
virus.
“Nobody says that new, fresh ideas cannot come out of
Nigeria. We should not underestimate the intelligence of Nigerians. I do
not underestimate the intelligence of our professionals, I believe
something positive is going to come out.”
Meanwhile, despite
being on a five-week long strike, the Nigerian Medical Association, NMA,
has set up a committee to combat the spread of thr virus. Speaking at a
press conference to sensitise the public of preventive measures against
the virus, the Chairman of the Lagos chapter of the NMA, Tope Ojo, said
a team of doctors from the state have already volunteered to help
patients at the Infectious Disease Hospital, Yaba, Lagos.
“Strike
or no strike, we must respond to emergencies. Our doctors are at
Mainland Hospital, Yaba, where isolated contacts are being monitored.
There are seven committees working on the management of the disease at
the centre in Lagos and our members are part of the various committees,”
he said.
“When there is disaster outbreak, you find out that
there will be response by NMA. The issue of strike will not affect our
involvement. The NMA is a responsible body and I can assure you that in
as much as we don’t pray for natural disasters, NMA will definitely
respond. We worked all through the night trying to find out who should
be here or there today. It is not a question of if the hospital is on
today we work more than what we have been doing.
“But the committee
where we are having challenges getting volunteers is case management.
This is the people that work directly with confirmed and suspected
cases.
“Look at the protective measures that doctors in Liberia
and Guinea wear. They are well protected, yet some of them still caught
it. Our doctors are worried about the danger it poses to their lives and
they need to be reassured. We understand their fears and we are making
moves to confirm the level of preparedness of the government for
doctors.”
Mr. Ojo also added that apart from the doctor who is
confirmed to have Ebola, a matron at the hospital is also showing
symptoms of the virus.
“We know that the infected doctor is
stable, however, the matron is now showing symptoms. But everybody
including the experts from the World Health Organisation are doing all
they can."
https://www.premiumtimesng.com/foreign/166118-%E2%80%8Eebola-nigeria-reaches-out-to-u-s-for-experimental-drug-nma-sets-up-committee.html#sthash.LG24zcS4.dpuf
No comments:
Post a Comment